219 related articles for article (PubMed ID: 27836895)
1. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
[TBL] [Abstract][Full Text] [Related]
2. Long-term dietary quercetin enrichment as a cardioprotective countermeasure in mdx mice.
Ballmann C; Denney T; Beyers RJ; Quindry T; Romero M; Selsby JT; Quindry JC
Exp Physiol; 2017 Jun; 102(6):635-649. PubMed ID: 28192862
[TBL] [Abstract][Full Text] [Related]
3. Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment.
Ballmann C; Hollinger K; Selsby JT; Amin R; Quindry JC
Exp Physiol; 2015 Jan; 100(1):12-22. PubMed ID: 25557727
[TBL] [Abstract][Full Text] [Related]
4. Long-term quercetin dietary enrichment decreases muscle injury in mdx mice.
Hollinger K; Shanely RA; Quindry JC; Selsby JT
Clin Nutr; 2015 Jun; 34(3):515-22. PubMed ID: 24998094
[TBL] [Abstract][Full Text] [Related]
5. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
[TBL] [Abstract][Full Text] [Related]
6. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
7. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
8. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle.
Spaulding HR; Ballmann CG; Quindry JC; Selsby JT
PLoS One; 2016; 11(12):e0168293. PubMed ID: 27977770
[TBL] [Abstract][Full Text] [Related]
10. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy.
Janssen PM; Murray JD; Schill KE; Rastogi N; Schultz EJ; Tran T; Raman SV; Rafael-Fortney JA
PLoS One; 2014; 9(2):e88360. PubMed ID: 24551095
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
[TBL] [Abstract][Full Text] [Related]
14. Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.
Selsby JT; Ballmann CG; Spaulding HR; Ross JW; Quindry JC
J Physiol; 2016 Oct; 594(20):6037-6053. PubMed ID: 27094343
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.
Gordon BS; Delgado Díaz DC; Kostek MC
Clin Nutr; 2013 Feb; 32(1):104-11. PubMed ID: 22795790
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
17. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
Li D; Long C; Yue Y; Duan D
Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
Barker RG; Wyckelsma VL; Xu H; Murphy RM
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
[TBL] [Abstract][Full Text] [Related]
19. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
[TBL] [Abstract][Full Text] [Related]
20. Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin.
Chan MC; Rowe GC; Raghuram S; Patten IS; Farrell C; Arany Z
Skelet Muscle; 2014 Jan; 4(1):2. PubMed ID: 24447845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
